Products and Patients
Amgen’s overall mission is to serve patients, which we consider a privilege.
Amgen gathers and analyses safety data throughout a product’s life cycle. Product safety is rigorously evaluated during the development process through clinical trials. Once a product is approved, safety data collection continues through multiple pathways, including additional clinical studies, reports by patients and health care professionals, registries, scientific literature, and database reviews.
Amgen is committed to providing accurate, up to date and transparent information to patients and their prescribers on all the risk and benefits related to our products. We understand that the ultimate use of the product depends on the individual benefit/risk decision made by patients and their prescribers.
If you wish to contact Amgen for any of the following reasons:
- You may have experienced an adverse event ('side effect') after taking or using an Amgen product
- There may be a defect or quality issue with the Amgen product you have received
- You have a general medical information enquiry about your Amgen product
Please call us on +61 2 9870 1333 and provide the details.
Medical Information Line – 1800 803 638